Jason Kralic

Jason Kralic, Ph.D., Board Member & CEO, is co-founder of Tellus, a neuropharmacologist and life sciences business development executive with broad experience in technology innovation, neurology/psychiatry R&D, company creation and licensing. Jason was Head of Neurosciences Business Development at GlaxoSmithKline where he was responsible for setting the BD strategy, leading licensing and M&A activities and facilitating relationships with alliance partners. Jason led the Technology Innovation team at Wake Forest Baptist Medical Center where he worked with research and clinical investigators to identify, patent, develop and commercialize therapeutics, medical devices and healthcare IT solutions. He also led business development and scientific licensing activities at Opexa Therapeutics, UCB Pharma and Schwarz Biosciences and founded Innervate BD Solutions, a CNS technology and business advisory firm in 2015. Jason holds a PhD in pharmacology from the University of North Carolina at Chapel Hill and completed post-doctoral training at the University of Zurich.